Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


Articles published in Leukemia

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    September 2017
  1. SAKAMOTO KM, Narla A
    Perspective on Diamond-Blackfan anemia: lessons from a rare congenital bone marrow failure syndrome.
    Leukemia. 2017 Sep 8. pii: leu2017314. doi: 10.1038/leu.2017.
    PubMed     Text format    


    August 2017
  2. ALBITAR A, Townsley D, Ma W, De Dios I, et al
    Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA As compared with BM.
    Leukemia. 2017 Aug 23. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    June 2017
  3. PLATZBECKER U, Symeonidis A, Oliva EN, Goede JS, et al
    A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes.
    Leukemia. 2017 Jun 19. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    March 2017
  4. ROSS DM
    Responses to pomalidomide and placebo in myelofibrosis-related anaemia.
    Leukemia. 2017;31:532-533.
    PubMed     Text format    


    February 2017
  5. DU W, Amarachintha S, Wilson A, Pang Q, et al
    The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion.
    Leukemia. 2017;31:423-433.
    PubMed     Text format     Abstract available


    January 2017
  6. HAJEK R, Masszi T, Petrucci MT, Palumbo A, et al
    A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).
    Leukemia. 2017;31:107-114.
    PubMed     Text format     Abstract available


    September 2016
  7. MUPO A, Seiler M, Sathiaseelan V, Pance A, et al
    Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts.
    Leukemia. 2016 Sep 8. doi: 10.1038/leu.2016.
    PubMed     Text format     Abstract available


    August 2016
  8. PATNAIK MM, Lasho TL, Finke CM, Hanson CA, et al
    Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T).
    Leukemia. 2016 Aug 1. doi: 10.1038/leu.2016.
    PubMed     Text format     Abstract available


    October 2015
  9. TOMA A, Kosmider O, Chevret S, Delaunay J, et al
    Lenalidomide with or without erythropoietin in transfusion dependent erythropoiesis-stimulating agent-refractory lower risk MDS without 5q deletion.
    Leukemia. 2015 Oct 26. doi: 10.1038/leu.2015.
    PubMed     Text format     Abstract available


  10. ROGERS KA, Ruppert AS, Bingman A, Andritsos LA, et al
    Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia.
    Leukemia. 2015 Oct 7. doi: 10.1038/leu.2015.
    PubMed     Text format     Abstract available


    June 2015
  11. KODE A, Mosialou I, Manavalan SJ, Rathinam CV, et al
    FoxO1-Dependent induction of acute myeloid leukemia by osteoblasts in mice.
    Leukemia. 2015 Jun 25. doi: 10.1038/leu.2015.
    PubMed     Text format     Abstract available


    May 2015
  12. JAAKO P, Debnath S, Olsson K, Zhang Y, et al
    Disruption of the 5S RNP-Mdm2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia.
    Leukemia. 2015 May 19. doi: 10.1038/leu.2015.
    PubMed     Text format     Abstract available


  13. DOLATSHAD H, Pellagatti A, Fernandez-Mercado M, Yip BH, et al
    Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
    Leukemia. 2015;29:1092-103.
    PubMed     Text format     Abstract available


  14. STAFFAS A, Karlsson C, Persson M, Palmqvist L, et al
    Wild-type KRAS inhibits oncogenic KRAS-induced T-ALL in mice.
    Leukemia. 2015;29:1032-40.
    PubMed     Text format     Abstract available


    October 2014
  15. LOUGHRAN TP JR, Zickl L, Olson TL, Wang V, et al
    Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the eastern cooperative oncology group (E5998).
    Leukemia. 2014 Oct 13. doi: 10.1038/leu.2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: